Inhibition potential of Moringa oleifera Lam. on drug metabolizing enzymes

Indian Journal of Traditional Knowledge

Volumn 14, Issue 4, 2015, Pages 614-619

  Ahmmed, S K Milan ^a   Mukherjee, Pulok K ^a   Bahadur, Shiv ^a   Kar, Amit ^a   Al Dhabi, Naif Abdullah ^b   Duraipandiyan, V ^b  

^a JADAVPUR UNIVERSITY   (India)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Chlorogenic acid; Cyp isozymes; HPTLC; Indian system of medicine; Moringa oleifera Lam; RLM

Indexed keywords

EID: 84945411460     PISSN: 09725938     EISSN: 09751068     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hannan MA, Kang JY, Mohibbullah M, Hong YK, Lee HS, Choi JS, Choi IS & Moon IlS, Moringa oleifera with promising neuronal survival and neurite outgrowth promoting potentials, J Ethnopharmacol, 152 (2014) 142-150.
2. Fahey JW, Moringa oleifera: a review of the medical evidence for its nutritional, therapeutic, and prophylactic properties, Phytochemistry, 47 (2005) 123-157.
3. Mohan M, Kaul N, Punekar A, Girnar R, Junnare P & Patil L, Nootropic activity of Moringa oleifera leaves, J Nat Rem, 5 (2005) 59-62.
4. Ganguly R & Guha D, Alteration of brain monoamines & EEG wave pattern in rat model of Alzheimer's disease & protection by Moringa oleifera, Indian J Med Res, 128(6) (2008) 744-751.
5. Arora DS & Onsare JG, In vitro antimicrobial evaluation and phytoconstituents of Moringa oleifera pod husks, Ind Crops Prod, 52 (2014) 125-135.
6. Ganzera M, Schneider P & Stuppner H, Inhibitory effects of the essential oil of chamomile (Matricaria recutita L.) and its major constituents on human cytochrome P450 enzymes, Life Sci, 78 (2006) 856-861.
7. Lee SY, Lee J, Kang W, Kwon K, Park S, Oh SJ, Ma JY & Kim SK, Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang, Food Chem Toxicol, 51 (2013) 343-349.
8. Pandit S, Mukherjee PK, Mukherjee K, Gajbhiye R, Venkatesh M, Ponnusankar S & Bhadra S, Cytochrome P450 inhibitory potential of selected Indian spices-possible food drug interaction, Food Res Int, 45 (2012) 69-74.
9. Mukherjee PK, Ponnusankar S, Pandit S, Hazam PK, Ahmmad M & Mukharjee K, Botanicals as medicinal food and their effects on drug metabolizing enzymes, Food Chem Toxicol, 49 (2011) 3142-3153.
10. Heinrich M, Modarai M & Kortenkamp A, Herbal extracts used for upper respiratory tract infections: Are there clinically relevant interactions with the Cytochrome P450 enzyme system?, Planta Med, 74 (2008) 657-660.
11. Rietjens IMCM, Slobb W, Galli C & Silano V, Risk assessment of botanicals and botanical preparations intended for use in food and food supplements: Emerging issues, Toxicol Lett, 180 (2008) 131-136.
12. st edn, (Pharmaceutical Press: London), 2009.
13. Pandit S, Mukherjee PK, Ponnusankar S, Venkatesh M & Srikanth N, Metabolism mediated interaction of α-asarone and Acorus calamus with CYP3A4 and CYP2D6, Fitoterapia, 82 (2011) 369-374.
14. Pandit S, Ponnusankar S, Bandyopadhyay A, Ota S & Mukherjee PK, Exploring the possible metabolism mediated interaction of Glycyrrhiza glabra extract with CYP3A4 and CYP2D6, Phytother Res, 25 (2011) 1429-1434.
15. Harwansh RK, Mukherjee K, Bhadra S, Kar A, Bahadur S, Mitra A & Mukherjee PK, Cytochrome P450 inhibitory potential and RP-HPLC standardization of trikatu – a rasayana from Indian Ayurveda, J Ethnopharmacol, 153 (2014) 674-681.